. 使仿T

Adrian-Bogdan Tigu1, Madalina Nistor1, Diana Gulei1

  • 1Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Blood reviews
|November 29, 2025
PubMed
概括

化学抗原受体 (CAR) T细胞疗法通过向有害的免疫细胞,对自身免疫性疾病呈现有前景. 这种方法旨在恢复免疫平衡,并为狼和多发性硬化症等疾病提供持久的缓解.